MedPath

The effect of Sulforaphane on the treatment of mild to moderate depression in post percutaneous coronary intervention patients

Phase 2
Recruiting
Conditions
Depression.
Major depressive disorder, single episode, moderate
F32.1
Registration Number
IRCT20090117001556N128
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Based on DSM-5 diagnostic criteria, have minor depression disorder
Based on Hamilton depression scale, get the score of 14 to 17
Age between 40 to 65 years
History of percutaneous coronary intervention

Exclusion Criteria

Pregnant or lactating women
Presence of other psychiatric disorders
Be psychotic
History of Electroconvulsive therapy, two months prior to the trial
Using psychotropic drug
Drug addiction
Presence of Thyroid disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath